Clinical Trails of Photoelectrochemical Immunosensor for Early Diagnosis of Acute Myocardial Infarction

Bin He

Status: Unknown

Conditions: Acute Myocardial Infarction

Treatments: Device: Graphene quantum dots combined with Si nanowire photoelectrochemical immunosensor

Study type: Interventional

Funder types: Other

Identifiers

NCT04390490

XH-20-007

Details and patient eligibility

About

The aim of this prospective randomized controlled clinical trial will evaluate the sensitivity, precision and effectiveness of photoelectrochemical immunosensor for early diagosis of acute myocardial infarction.

Enrollment: 100 estimated patients

Sex: All

Ages: 18 to 100 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Age > 18 years
• Symptoms of chest pain

Exclusion criteria

• Patients who will undergo immediate PCI Pregnant
• Lactating women
• Patients with mental disorders
• Patients are using other experimental drugs; Refusal to provide informed.

Trial design

Primary purpose: Diagnostic

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Quadruple Blind

---

100 participants in 2 patient groups

control

No Intervention group

Description:

Automatic chemiluminescence analyzer will be used for dectecting the concentration of cardiac troponin I as control group.

Photoelectrochemical immunosensor

Experimental group

Description:

Photoelectrochemical immunosensor will be used for dectecting the concentration of cardiac troponin I as test group.

Treatment:

Device: Graphene quantum dots combined with Si nanowire photoelectrochemical immunosensor